{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:58:23Z","timestamp":1772161103616,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T00:00:00Z","timestamp":1442275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1136\/annrheumdis-2015-207760","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T01:48:54Z","timestamp":1442368134000},"page":"1336-1342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study"],"prefix":"10.1016","volume":"75","author":[{"given":"Cem","family":"Gabay","sequence":"first","affiliation":[]},{"given":"Myriam","family":"Riek","sequence":"additional","affiliation":[]},{"given":"Merete Lund","family":"Hetland","sequence":"additional","affiliation":[]},{"given":"Ellen-Margrethe","family":"Hauge","sequence":"additional","affiliation":[]},{"given":"Karel","family":"Pavelka","sequence":"additional","affiliation":[]},{"given":"Matija","family":"Tom\u0161i\u010d","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Canhao","sequence":"additional","affiliation":[]},{"given":"Katerina","family":"Chatzidionysiou","sequence":"additional","affiliation":[]},{"given":"Galina","family":"Lukina","sequence":"additional","affiliation":[]},{"given":"Dan C","family":"Nordstr\u00f6m","sequence":"additional","affiliation":[]},{"given":"Elisabeth","family":"Lie","sequence":"additional","affiliation":[]},{"given":"Ioan","family":"Ancuta","sequence":"additional","affiliation":[]},{"given":"M Victoria","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[]},{"given":"Piet L M C","family":"van Riel","sequence":"additional","affiliation":[]},{"given":"Ronald","family":"van Vollenhoven","sequence":"additional","affiliation":[]},{"given":"Tore K","family":"Kvien","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2015-207760_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2015-207760_bib2","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/ard.2008.092932","article-title":"IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial","volume":"67","author":"Emery","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2015-207760_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3899\/jrheum.120447","article-title":"Tocilizumab inhibits structural joint damage and improves physical function in patients with rheumatoid arthritis and inadequate responses to methotrexate: LITHE study 2-year results","volume":"40","author":"Fleischmann","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2015-207760_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2015-207760_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.21519","volume":"54","author":"Breedveld","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2015-207760_bib6","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","article-title":"Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial","volume":"363","author":"Klareskog","year":"2004","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2015-207760_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/ard.2010.139774","article-title":"Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register","volume":"70","author":"Soliman","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2015-207760_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/annrheumdis-2011-201282","article-title":"Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)","volume":"72","author":"Dougados","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2015-207760_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/annrheumdis-2013-204761","article-title":"Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study","volume":"73","author":"Dougados","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2015-207760_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/annrheumdis-2014-205752","article-title":"Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study","volume":"74","author":"Huizinga","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 3","key":"10.1136\/annrheumdis-2015-207760_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/annrheumdis-2013-eular.245","article-title":"Adding Tocilizumab or switching to Tocilizumab monotherapy in RA patients with inadequate response to Methotrexate: 24-week results from a randomized controled study (surprise study)","volume":"72","author":"Takeuchi","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2015-207760_bib12","doi-asserted-by":"crossref","unstructured":"Gabay C, Riek M, Scherer A, et al. Effectiveness of biological DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis\u2014data from the Swiss Clinical Quality Management Registry. Rheumatology (Oxford) Published Online First: 27 Apr 2015.","DOI":"10.1093\/rheumatology\/kev019"},{"key":"10.1136\/annrheumdis-2015-207760_bib13","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(13)60250-0","article-title":"Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial","volume":"381","author":"Gabay","year":"2013","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1136\/annrheumdis-2015-207760_bib14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/annrheumdis-2014-eular.2439","article-title":"Clinical and radiographic effects after 52-week of adding Tocilizumab or switching to tocilizumab in RA patients with inadequate response to methotrexate: results from a prospective randomized controlled study (SURPRISE study)","volume":"73","author":"Takeuchi","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2015-207760_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10067-014-2857-y","article-title":"Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice","volume":"34","author":"Bykerk","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2015-207760_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/rheumatology\/keu302","article-title":"Importance of methotrexate therapy concomitant with tocilizumab treatment in achieving better clinical outcomes for rheumatoid arthritis patients with high disease activity: an observational cohort study","volume":"54","author":"Kojima","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2015-207760_bib17","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1002\/sim.3944","article-title":"Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values","volume":"29","author":"White","year":"2010","journal-title":"Stat Med"},{"key":"10.1136\/annrheumdis-2015-207760_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0049124100028003003","article-title":"Multiple imputation for missing data: a cautionary tale","volume":"28","author":"Allison","year":"2000","journal-title":"Sociol Method Res"},{"key":"10.1136\/annrheumdis-2015-207760_bib19","series-title":"Statistical analysis with missing data","author":"Little","year":"2002"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724017904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724017904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2015-207760","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T08:27:57Z","timestamp":1739521677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724017904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0003496724017904"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2015-207760","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2015-207760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}